Precision Optics Corp Inc/Mass (POCI)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · POCI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -61.3% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 18.1% |
Growth built into the price is above our model estimate.
The price assumes 79.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 26 industry peers
POCI — debt issuance
Dated 2026-03-30
Entry into a Material Definitive Agreement. Underwriting Agreement On March 27, 2026, Precision Optics Corporation, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lucid Capital Markets, LLC (the “Underwriter”), relating to the issuance and sale (the “Offering”) of 2,777,777 shares of its common stock, par value $0.01 per share, at a price to the public of $3.60 per share. In connection with the Offering, the Company has granted the Underwriter…
Why it matters: Updates on capital allocation show how well the company is managing its resources. This affects future growth.
Watch forManagement has a clear plan for spending money in Q3 earnings.
Also watch forNo news or unclear plans on how money will be spent in Q3 earnings.
Why it matters: Revenue growth is crucial to show the company is moving past losses. Positive growth can signal a turnaround.
Supportive ifQ2 revenue growth reported above 5% year over year.
Worry ifQ2 revenue growth reported below 0% year over year.
Why it matters: Effective capital allocation can drive growth and improve financial health. Investors will want clarity on future plans.
Watch forManagement has a clear plan for using money. This plan will help financial results.
Also watch forNo news on capital use plans or more delays in starting them.
Why it matters: A drop in revenue growth could signal a slowdown in strategic initiatives. This would affect investor confidence.
Worry ifRevenue growth remains above 10% year over year in the next earnings report.
Less concerning ifRevenue growth drops below 10% year over year in the next earnings report.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$181 on $10,000 · ±1.8% | How much price usually moves either way. |
| Bad day | $441 loss on $10,000 · 4.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,434 loss on $10,000 · 34.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A drop below median growth signals a potential slowdown in the healthcare sector. This could impact POCI's growth.
Worry ifHealthcare sector revenue growth reported below its median.
Less concerning ifHealthcare sector revenue growth remains above its median.
Why it matters: If the health care sector grows again, it could help POCI's results. This matters for market mood.
Watch forSector revenue growth speeds up to over 12% year over year.
Also watch forSector revenue growth slows down to under 5% year over year.
Why it matters: Good capital use is important for growth. Updates can explain management's plans.
Watch forManagement will share a clear plan for capital use in the next earnings call.
Also watch forManagement does not talk about capital use in the next earnings call.
Why it matters: Strong revenue growth would show that strategic initiatives are working well. This could boost investor confidence.
Supportive ifQ3 revenue growth exceeds 30% compared to Q3 last year.
Worry ifQ3 revenue growth is below 20% year over year.
Why it matters: Higher margins show better cost control. This can attract more investors.
Supportive ifGross profit margins improve to over 25% in Q3.
Worry ifGross profit margins stay below 20% in Q3.